GlassScriptPhysician profile
Sarah J Wilson
NPI 1588041099
$7,676.75
in general payments reported to CMS, 2019-2025
30 companies · $1,488 in 2025
The $1,488 reported for 2025 was more than what 83% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $509 · 2021: $467 · 2022: $1,406 · 2023: $1,769 · 2024: $2,038 · 2025: $1,488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,215 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,214.89 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,463.02 | 2022-2025 | |
| Abbvie INC. | $1,118.64 | 2021-2025 | Skyrizi, Rinvoq |
| Merz North America, INC. | $798.63 | 2020-2024 | Xeomin |
| Regeneron Healthcare Solutions, INC. | $639.96 | 2021-2025 | Dupixent, Libtayo |
| E.R. Squibb & Sons, L.L.C. | $585.96 | 2022-2024 | Sotyktu |
| Janssen Biotech, INC. | $473.60 | 2021-2025 | Tremfya, Simponi, Stelara |
| Novartis Pharmaceuticals Corporation | $472.66 | 2021-2025 | |
| Incyte Corporation | $399.15 | 2022-2024 | Opzelura |
| Sun Pharmaceutical Industries INC. | $364.13 | 2021-2025 | Ilumya, Odomzo, Blu-U |
| Lilly USA, LLC | $275.81 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Leo Pharma INC. | $268.01 | 2021-2025 | Adbry, Anzupgo |
| Amgen INC. | $129.60 | 2022-2025 | Otezla, Otezla |
| Dermavant Sciences, INC. | $92.88 | 2023-2024 | Vtama |
| Mayne Pharma Commercial LLC | $66.73 | 2024-2025 | |
| Organogenesis INC. | $51.25 | 2023-2024 | Puraply |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $49.60 | 2024-2025 | Nemluvio |
| Arcutis Biotherapeutics, INC. | $40.59 | 2025 | Zoryve |
| Kerecis Limited | $39.59 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $39.52 | 2025 | Cabtreo, Siliq, Jublia |
| Botanix Sb INC | $38.03 | 2025 | Sofdra |
| Almirall LLC | $37.08 | 2022-2023 | Seysara |
| Surgenex LLC | $35.37 | 2025 | Pellograft, Surmatrix, Ardeograft |
| Medline Industries LP | $34.11 | 2024 | |
| Ucb, INC. | $26.88 | 2022 | |
| Pfizer INC. | $26.85 | 2023-2024 | |
| Acera Surgical, INC. | $24.64 | 2020 | |
| Convatec INC. | $24.56 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.44 | 2023 | Spevigo |
| Lupin INC. | $19.87 | 2021 | |
| Lnhc, INC | $18.59 | 2025 | Zelsuvmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.